Vimarsana
Biggest News Aggregation in the World

Page 16 - One Dose News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from One Dose. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In One Dose Today - Breaking & Trending Today

COVID survivors might need just one vaccine dose, not two - Vimarsana News

COVID survivors might need just one vaccine dose, not two

Amid the shortage of COVID-19 vaccines, some new research offers a potential way to free up supply: give people who have recovered from the virus just one dose instead of two.

Source: 10news.com
14% of Rochester Area Residents Have Started COVID Vaccinations - Vimarsana News

14% of Rochester Area Residents Have Started COVID Vaccinations

Enter your number to get our free mobile app Rochester, MN (KROC-AM News) - An updated COVID-19 vaccination report from the state indicates 14 percent of Olmsted County residents have now received at least one dose of the vaccine. That equates to almost 21,500 people. Almost 5300 Olmsted County residents have received both vaccination shots. Only Mahnomen County in northwestern Minnesota has a vaccination rate of over 18 percent but the number of people vaccinated is far smaller at just over 1000. Statewide, over 284,000 Minnesotans have received at least one dose and over 67,500 have had bot...

Source: kroc.com
Johnson & Johnson's COVID-19 vaccine shows promising response in early trial after one dose - Vimarsana News

Johnson & Johnson's COVID-19 vaccine shows promising response in early trial after one dose

Johnson & Johnson’s COVID-19 vaccine shows promising response in early trial after one dose Johnson & Johnson and last updated 2021-01-14 12:20:55-05 Results from early stage trials of Johnson & Johnson’s COVID-19 vaccine are promising, showing the one-dose vaccine generates an immune response in nearly all volunteers, with minimal side effects. The company plans to release more details in a few weeks, and apply for emergency use authorization from the FDA in February. Researchers say Phase 1-2 of the vaccine showed either one or two doses of the vaccine generated both antibody and...

Source: ksby.com
Covid-19: Russia's new 'light' one-dose vaccine to fight rising infections? - News - Vimarsana News

Covid-19: Russia's new 'light' one-dose vaccine to fight rising infections? - News

Russian official says 'light' version of vaccine would be around 85% effective.